In a few decades, Algeria has risen to the level of the main pharmaceutical producers in Africa. In a post-Covid period, Who highlighted the need for the whole continent to reduce its dependence on imports of medical equipment, the country has succeeded, through its 200 pharmaceutical units, including 137 specialized In drug production, to reduce its drug import bill by $800 million. Which went from $2 billion in 2019 to $1.2 billion in 2022.
